Related Experiment Videos
Regulated association of microtubule-associated protein 2 (MAP2) with Src and Grb2: evidence for MAP2 as a
1Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
Microtubule-associated protein 2 (MAP2) and tau, which is involved in Alzheimer's disease, are major cytoskeletal proteins in neurons. These proteins are involved in microtubule assembly and stability. To further characterize MAP2, we took a strategy of identifying potential MAP2 binding partners. The low molecular weight MAP2c protein has 11 PXXP motifs that are conserved across species, and these PXXP motifs could be potential ligands for Src homology 3 (SH3) domains. We tested for MAP2 interaction with SH3 domain-containing proteins. All neuronal MAP2 isoforms bound specifically to the SH3 domains of c-Src and Grb2 in an in vitro glutathione S-transferase-SH3 pull-down assay. Interactions between endogenous proteins were confirmed by co-immunoprecipitation using brain lysate. All three proteins were also found co-expressed in neuronal cell bodies and dendrites. Surprisingly, the SH3 domain-binding site was mapped to the microtubule-binding domain that contains no PXXP motif. Src bound primarily the soluble, non-microtubule-associated MAP2c in vitro. This specific MAP2/SH3 domain interaction was inhibited by phosphorylation of MAP2c by the mitogen-activated protein kinase extracellular signal-regulated kinase 2 but not by protein kinase A. This phosphorylation-regulated association of MAP2 with proteins of intracellular signal transduction pathways suggests a possible link between cellular signaling and neuronal cytoskeleton, with MAP2 perhaps acting as a molecular scaffold upon which cytoskeleton-modifying proteins assemble and dissociate in response to neuronal activity.
Insights
Microtubule-associated protein 2 (MAP2) binds to SH3 domains of c-Src and Grb2, revealing a link between neuronal signaling and the cytoskeleton. This interaction is regulated by MAP2c phosphorylation, suggesting MAP2 acts as a scaffold for signaling proteins.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Microtubule-associated protein 2 (MAP2) and tau are key neuronal cytoskeletal proteins regulating microtubule stability.
- Alzheimer's disease is linked to tau pathology.
- Understanding MAP2 interactions is crucial for neuronal function.
Purpose of the Study:
- To identify and characterize MAP2 binding partners.
- To investigate the interaction between MAP2 and Src homology 3 (SH3) domain-containing proteins.
- To explore the functional implications of MAP2-SH3 domain interactions.
Main Methods:
- Glutathione S-transferase-SH3 pull-down assays to test in vitro binding.
- Co-immunoprecipitation using brain lysate to confirm endogenous interactions.
- Mapping of the SH3 domain-binding site on MAP2.
Main Results:
- All MAP2 isoforms specifically bound to SH3 domains of c-Src and Grb2.
- Endogenous MAP2, c-Src, and Grb2 were co-immunoprecipitated and co-expressed in neurons.
- The SH3 binding site was mapped to the microtubule-binding domain of MAP2.
- Src preferentially bound soluble, non-microtubule-associated MAP2c.
- Phosphorylation of MAP2c by extracellular signal-regulated kinase 2 inhibited Src binding.
Conclusions:
- MAP2 interacts with SH3 domain-containing proteins like c-Src and Grb2.
- This interaction is regulated by MAP2c phosphorylation, linking intracellular signaling to the neuronal cytoskeleton.
- MAP2 may function as a scaffold protein, integrating neuronal activity with cytoskeletal dynamics.